Updated:
Encore Well Labs Plus GP
Encore Well Labs Plus GP is a health and longevity investment vehicle deploying through a GP structure, focused on early-stage bio-wellness companies.
Encore Well Labs Plus GP
Encore Well Labs Plus GP, LLC is an exempt reporting adviser with its main office in Clayton, MO. The firm provides investment advice to clients.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
Frequently asked questions
How does Encore Well Labs Plus GP likely source its investment opportunities?
Based on its name and structure, deal flow probably originates from proprietary networks within academic medical centers, biotech incubators, or specialized longevity research communities. GP-led vehicles without broad marketing often rely on deep relationships with scientific founders, technology transfer offices, or serial entrepreneur partners who repeatedly bring opportunities to the manager.
Does Encore Well Labs Plus GP disclose any past portfolio companies?
No. The firm does not maintain a public-facing website or portfolio page, and no portfolio companies have been identified through press releases, regulatory filings, or co-investor announcements. This level of operating discretion is common for concentrated health-science investment vehicles managing proprietary or non-institutional capital.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: